
Valerie
Empowering midlife women to thrive.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | £514k | Seed | |
Total Funding | 000k |
Valerie positions itself as a key player in the burgeoning femtech market, specifically targeting the healthcare needs of women undergoing perimenopause and menopause. The company was co-founded by Yasminנייםa Menezes and Vinay Ramharak. Menezes, who serves as CEO, brings a wealth of experience from her time as Global Brand & Marketing Director at Ted Baker, providing a strong foundation in brand building and consumer engagement. Ramharak, the CPO, contributes his expertise in product and technology, having previously worked as a product lead at the health-tech company Babylon. This blend of marketing and tech proficiency in the founding team is central to Valerie's strategy.
The company's core business revolves around a direct-to-consumer model, focusing on providing women with effective tools to manage the physical and emotional symptoms associated with hormonal changes in midlife. Valerie's flagship product is the 'Daily Essential' supplement, which utilizes liposomal nanotechnology. This delivery system is designed to enhance the absorption of its ingredients, which are intended to address 76 distinct health and beauty concerns related to menopause. The business generates revenue through the sale of these supplements. By addressing a significant and often underserved demographic, Valerie aims to build a strong community and brand loyalty, empowering women to take proactive control of their health during this transitional phase of life.
Keywords: femtech, menopause, perimenopause, supplements, direct-to-consumer, women's health, wellness, liposomal, nanotechnology, healthcare